| 1. Study on the optimal waist circumference cut-off points of metabolic syndrome in Kazakh |
Page:40—42 |
| 2. Association of iodine nutrition and thyroid health conditions among residents in Zhoushan archipelago |
Page:28—31 |
| 3. Clinical features of 18 patients with adrenocortical oncocytoma |
Page:14—16 |
| 4. Expressions and significance of two kinds of vascular endothelial growth factors of different origin in adrenocortical lesions of primary aldosteronism |
Page:9—13 |
| 5. ACTH-independent macronodular adrenal hyperplasia: report of 12 cases |
Page:5—8 |
| 6. Association of single nucleotide polymorphism of transcription factor 7-like 2 gene with gestational diabetes mellitus |
Page:32—35 |
| 7. Characteristics of 42 cases of incidental discovery of pheochromocytoma |
Page:17—18 |
| 8. Association of serum uric acid level with coronary artery lesion and metabolic syndrome |
Page:24—27 |
| 9. Clinical management and postoperative follow up of 12 patients with tumor-induced osteomalacia |
Page:19—23 |
| 10. How to raise the awareness of adrenal hypertension in China |
Page:2—4 |
| 11. Pigment epithelium-derived factor inhibits high glucose-stimulated transforming growth factor β1,fibronectin, and collagen Ⅳ expressions in human mesangial cells |
Page:70—71 |
| 12. Long-term impacts of post-transplant diabetes mellitus on transplant recipients |
Page:95—98 |
| 13. Progress in pharmaceutical treatment for adrenocotical carcinoma |
Page:91—94 |
| 14. Effects of rosiglitazone on pigment epithelium-derived factor, matrix metalloproteinase-2, and transforming growth factor-β1 expressions in diabetic rats kidney |
Page:66—69 |
| 15. Effects of insulin and β-adrenergic agonist on adiponectin secretion and expression in rats |
Page:62—65 |
| 16. Role of Wnt/β-catenin signaling pathway in impaired wound healing of diabetes mellitus |
Page:57—61 |
| 17. Value of HbA1C in the diagnosis of type 2 diabetes during an epidemiological survey of diabetes in the elderly of Nanchang community |
Page:50—52 |
| 18. One case of late-onset adrenal hypoplasia congenita caused by a novel mutation of DAX-1 gene |
Page:47—49 |
| 19. Recurrent lymphocytic hypophysitis successfully treated with glucocorticoids plus azathioprine: three cases report |
Page:43—46 |
| 20. Plasma kisspeptin levels in normal female pubertal stages and in girls with idiopathic central precocious puberty |
Page:36—39 |
| 21. Key issues in the diagnosis of osteoporosis |
Page:101—105 |
| 22. The pituitary-bone axis in bone metabolism |
Page:184—188 |
| 23. Notion to the significance of somatotropic axis, gonadal hormones with their post receptor signaling for growth modulating, and relevant treatment during adolescence with growth disorders |
Page:277—282 |
| 24. Effects of gonadotropin-releasing hormone analogue treatment on adrenarche in girls with idiopathic central precocious puberty |
Page:283—286 |
| 25. Final adult height in girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogue and growth hormone |
Page:287—291 |
| 26. Gender-related differences in patients with Graves' disease |
Page:311—314 |
| 27. Efficacy of treatment with gonadotropin-releasing hormone analogue alone or combined with recombinant human growth hormone in pubertal short children |
Page:292—295 |
| 28. Association between linear growth patterns with serum insulin levels in pre-pubertal children born small for gestational age |
Page:296—300 |
| 29. Relationship between serum visfatin level and coronary artery stenosis in patients with different glucose tolerance |
Page:303—306 |
| 30. Analysis of urinary iodine levels in normal pregnant Chinese women in four districts |
Page:307—310 |
| 31. A case with 21-hydroxylase deficiency combined with adrenal adenoma and testicular adrenal rest tumors |
Page:315—319 |
| 32. The level of endogenous secretory receptor for advanced glycation end-products in type 2 diabetes patients is associated with carotid intima-media thickness |
Page:320—321 |
| 33. Application of weighted topsis method in evaluating the key factors of medical management of diabetes mellitus |
Page:322—323 |
| 34. Effect of insulin therapy on serum level of insulin-like growth factor-I |
Page:324—325 |
| 35. Clinical significance of 99mTc thyroid scintigraphy in children with congenital hypothyroidism |
Page:326—327 |
| 36. Effects of advanced glycation end-products on matrix metalloproteinase 2 expression in INS-1 cells |
Page:328—331 |
| 37. Effects of chronic iodine excess on thyroid function and structure in autoimmune-prone NOD.H-2h4 mice |
Page:332—334 |
| 38. Transactivation of thyroid hormone receptor βΔ on target genes through thyroid hormone responsive element |
Page:335—336 |
| 39. Effect of icariside Ⅱ on the expression of osteoprotegerin in mouse osteoblasts |
Page:337—338 |
| 40. Progress in the study of the association between abnormal triglyceride metabolism and insulin resistance |
Page:357—359 |
| 41. Clinical implications of thyrotropin receptor antibody measurement |
Page:360—364 |
| 42. Study on the acetoacetate/β hydroxybutyrate determination in classification of type 1 and type 2 diabetes mellitus |
Page:229—231 |
| 43. The accuracy of real-time continuous monitoring system at different stages and its association with glucose excursion |
Page:224—228 |
| 44. Relationship between angiotensin Ⅱ and pancreatic islet β cell secretion function in patients with type 2 diabetes mellitus |
Page:219—223 |
| 45. Prevalence of abnormal glucose metabolism and preliminary investigation of its pathogenesis in patients being alive over 3 years after liver transplantation |
Page:215—218 |
| 46. Urinary interleukin-6 level was associated with urinary tract infection in patients with type 2 diabetes mellitus |
Page:213—214 |
| 47. Relationship between oxidative stress and the first-phase of glucose-stimulated insulin secretion from pancreatic β cell in individuals with different glucose tolerance |
Page:210—212 |
| 48. High glucose induced inflammatory response and fibrosis of human mesangial cells via Rho/ROCK signaling pathway |
Page:204—209 |
| 49. Recent advances in the relationship between BMP-6 and iron-overload osteoporosis |
Page:181—183 |
| 50. Study on the mechanism of SPARC in the development of insulin resistance |
Page:161—164 |
| 51. Adenoviral vector-mediated IGF-Ⅰ gene transfer protects NOD mice from diabetes |
Page:158—160 |
| 52. Effect of high-fat diet on gene expression related cholesterol metabolism in ApoE knockout mice |
Page:155—157 |
| 53. Effects of advanced glycation end products on cell viability and level of reactive oxygen species(ROS)in MIN6 cells |
Page:152—154 |
| 54. The expression of LXR and its impacts on hepatic glucose metabolism in different glucose metabolic statuses in rats |
Page:148—151 |
| 55. Benign symmetrical lipomatosis: a case report and review of literature |
Page:145—147 |
| 56. Frequency domain parameter of heart rate variability and its circadian rhythm in type 2 diabetes with lower extremity neuropathy |
Page:142—144 |
| 57. A Miao pedigree of Bardet-Biedl syndrome in Yunnan province and their gene reservation |
Page:137—141 |
| 58. Association of complement component 3 and high-sensitive C-reactive protein with insulin resistance index (HOMA2-IR)in non-diabetic population |
Page:133—136 |
| 59. Relationship between long-term mortality and diabetic complications in 139 patients with diabetic foot ulcer |
Page:128—132 |
| 60. The thyroid hornone receptor in human osteogenic sarcoma cell line MG-63 cell-T3 binding studies with nuclear extracts |
Page:125—127 |
| 61. Effect of p38MAPK in icariin induced osteoblast differentiation |
Page:122—124 |
| 62. Effect of pioglitazone on the expressions of Bax and Bcl-2 protein in mouse osteoblasts |
Page:118—121 |
| 63. Effect of calcitonin on analgesia and expression of calcitonin receptor in periaqueductal gray |
Page:113—117 |
| 64. Survey on medical therapy of patients with osteoporotic vertebrae fractures |
Page:110—112 |
| 65. Changes in bone mineral density and bone turnover in postmenopausal osteoporotic patients treated with salmon calcitonin nasal spray |
Page:106—109 |
| 66. Progress in the study of β-arrestins in glucose and lipid metabolism |
Page:274—276 |
| 67. Gonadotropins and bone metabolism |
Page:269—273 |
| 68. The expression and significance of p-IRE-1α in rat liver with insulin resistance |
Page:250—252 |
| 69. Effect of recombinant human connective tissue growth factor on the expression of membrane type-1 matrix metalloproteinase and matrix metalloproteinase 2 in human osteoblasts |
Page:246—249 |
| 70. Effect of thyroid hormones on the expression of thyroid hormone receptor isoforms in human osteogenic sarcoma cell line MG-63 |
Page:242—245 |
| 71. A survey on reference ranges for serum pituitary-thyroid hormones of 2-6 years old healthy Chinese children in Hangzhou |
Page:240—241 |
| 72. Correlation of serum uric acid and early renal damage in patients with type 2 diabetes mellitus |
Page:237—239 |
| 73. Relationship between the prevalence of hypertension and metabolic syndrome in minority populations of Baise, Guangxi province |
Page:234—236 |
| 74. Genetic diagnosis on one case of primary pigmented nodular adrenal disease |
Page:231—233 |
| 75. Effects of probucol on the expression of thioredoxin system in the kidney of type 2 diabetic rats |
Page:199—203 |
| 76. Effect of acarbose on levels of chronic inflammatory factors in patients with type 2 diabetes |
Page:193—198 |
| 77. Pay more attention to the role of macrophages in chronic low-grade inflammatory diseases |
Page:189—192 |
| 78. Therapeutic potential of sunitinib in the treatment of malignant islet cell tumor |
Page:618—620 |
| 79. The progress on the research of the relationship between hyperuricemia and cardiovascular disease |
Page:614—617 |
| 80. Recent progress in related genes of primary hyperuricemia and gout |
Page:611—613 |
| 81. The prevalence of heart failure with normal ejection fraction in diabetic foot ulcer and the change after treatment |
Page:580—583 |
| 82. The status of glycemic control in type 2 diabetes mellitus: a cross-sectional survey in Jiangsu province |
Page:575—579 |
| 83. Interaction between serum uric acid and metabolic risk factors in relation to hypertension |
Page:573—574 |
| 84. Epidemiological survey of hyperuricemia and gout in Xinjiang adult population |
Page:570—572 |
| 85. Relationship between serum uric acid and carotid atherosclerosis in male patients with type 2 diabetes |
Page:566—569 |
| 86. An epidemiological study on the prevalence of hyperuricemia and its relationship to chronic kidney disease in the urban community residents of Guangxi |
Page:561—565 |
| 87. A cross-sectional study on the association between serum uric acid and non-alcoholic fatty liver disease in health checkup population |
Page:557—560 |
| 88. A prospective study on gout in patients with hyperuricemia |
Page:553—556 |
| 89. A five years follow up study on patients with gout and hyperuricemia |
Page:548—552 |
| 90. Key problems in the prevention and treatment of hyperuricemia |
Page:543—547 |
| 91. Changes of serum gastrin and CCK2R expression of visceral adipocytes in catch-up rats |
Page:607—609 |
| 92. The function of hepatic oval cells under high glucose condition in vivo |
Page:604—606 |
| 93. Effects of liraglutide on the expression of genes related to cholesterol metabolism in ApoE-/-mice with hypoadiponectinemia |
Page:599—603 |
| 94. Protective effect of folic acid on osteoporosis in ovariectomized rats |
Page:594—598 |
| 95. Association of thyroglobulin gene polymorphisms with thyroglobulin autoantibody in patients with autoimmune thyroid disease |
Page:591—593 |
| 96. The relationship between serum vitamin D level and obesity |
Page:589—590 |
| 97. A novel mutation of SRY gene identified in a 46,XY complete gonadal dysgenesis patient |
Page:586—588 |
| 98. Effect of nateglinide or sequential treatment with metformin on glycemic stability in newly diagnosed type 2 diabetic patients |
Page:584—585 |
| 99. HbA1C:several considerations in clinical practice |
Page:365—366 |
| 100. HbA1C for diagnosing diabetes:past,present,and future |
Page:367—370 |
| 101. Cutpoint and clinical significance of HbA1C for diabetes diagnosis in a cross-sectional study |
Page:375—380 |
| 102. Relationship between HbA1C and microvascular complications in high-risk populations of diabetes |
Page:381—385 |
| 103. Poor performance of HbA1C in diagnosis of pre-diabetes in Chinese adolescents |
Page:386—389 |
| 104. Diagnostic value of HbA1C and fasting plasma glucose as early screening parameters for diabetes mellitus |
Page:390—392 |
| 105. Prevalence and associated risk factors of typc 2 diabetes mellitus in populations of Uigurs and Kazaks in xinjiang |
Page:395—398 |
| 106. Association of serum ferrltin with β-cell function and insulin resistance in elderly patients with type 2 diabetes and impaired glucose tolerance |
Page:399—403 |
| 107. A study on trends of the incidence of gestational diabetes mellitus and its relevant factors in Chongqing city from 2005 to 2009 |
Page:404—407 |
| 108. A continuous glycemic observation during early phase of acute myocardial infarction in patients without known diabetes mellitus |
Page:410—412 |
| 109. Association of β-amyloid peptide 40/42 with type 2 diabetes mellitus and atherosclerosis |
Page:413—414 |
| 110. Relationship between one-hour postload plasma glucose and carotid intima-media thickness in abdominal obese men |
Page:415—417 |
| 111. Study on binding capacity of low-density lipoprotein to its receptors in diabetic patients |
Page:418—419 |
| 112. Clinical efficacy of low-dose methimazole therapy in patients with subclinical hyperthyroidism complicated by paroxysmal atrial fibrillation |
Page:420—421 |
| 113. Effects of mitochondrial fission on the function of pancreatic β cells |
Page:422—426 |
| 114. Effects of tumor suppressor in lung cancer-1 overexpression on gene expressions involved in glucose and lipid metabolism in liver cells |
Page:429—431 |
| 115. Vaspin,obesity,and type 2 diabetes |
Page:448—450 |
| 116. Individualized thyrotropin suppression in patients with differentiated thyroid cancers |
Page:451—453 |
| 117. Biological feature of radioiodine-131 and use of potassium iodide in nuclear accident |
Page:454—457 |
| 118. The reference range of serum thyrotropin in iodine-sufficient areas: An epidemiological study |
Page:458—462 |
| 119. Recombinant human thyrotropin-aided radioiodine treatment of differentiated thyroid carcinoma |
Page:463—466 |
| 120. Relationship betweenserum TSH and dyslipidemia |
Page:467—470 |
| 121. Observation of serum oxidative and antioxidative indices in patients with Graves′ disease |
Page:495—497 |
| 122. Effects of metformin on thyrotropin: A preliminary study |
Page:471—473 |
| 123. Beneficial effects of intensive therapy on arterial intima-media thickness and its risk factors in type 2 diabetic patients |
Page:474—477 |
| 124. Association of TSHR gene intron 1 polymorphisms with Graves′ disease |
Page:478—481 |
| 125. Efficacy of maggot debridement therapy in the treatment of diabetic foot ulcers |
Page:482—484 |
| 126. Immunological characteristics and pancreatic β-cell function in first-degree relatives of type 1 diabetes mellitus |
Page:485—488 |
| 127. Genetic analysis of neonatal diabetes mellitus and its influence on treatment outcome |
Page:488—491 |
| 128. Epidemiologic study on thyroid nodules in community population of Jiangsu |
Page:492—494 |
| 129. Genetic diagnosis and weight loss surgery of a case of Prader-Willi syndrome |
Page:498—501 |
| 130. Comparison of several early drug interventions in postmenopausal women with osteopenia |
Page:502—504 |
| 131. Gender difference in the establishment of animal model of Graves′ disease |
Page:505—508 |
| 132. Influence of the expression of parathyroid hormone 1 receptor to INS-1 cell function under high glucose condition |
Page:509—512 |
| 133. Effect of metformin on osteogenic and adipogenic differentiation of rat mesenchymal stem cells |
Page:513—517 |
| 134. Effect of RNAi targetingp38MAPK on high glucose-induced apoptosis of osteoblast MC3T3-E1 cell line |
Page:518—522 |
| 135. Utility of the BRAFT1799Amutation in papillary thyroid cancer |
Page:525—528 |
| 136. Update on the side effects of antithyroid drugs |
Page:529—532 |
| 137. Thyrotropin suppressive therapy in differentiated thyroid carcinoma |
Page:533—536 |
| 138. Research progress of dead-in-bed syndrome in type 1 diabetes |
Page:1032—1035 |
| 139. Approach to the patient with parathyroid adenoma and thyroid remnant goiter |
Page:1025—1027 |
| 140. Serum level of 25-dihydroxyvitamin D3 in patients with diabetic nephropathy |
Page:1002—1003 |
| 141. Analysis of basic research in endocrine and metabolic projects granted by National Natural Science Foundation of China |
Page:1017—1020 |
| 142. Expressions of estrogen receptor β1 and β2 in human thyroid neoplasms and its clinical implication |
Page:932—934 |
| 143. Prognostic factors of differentiated thyroid carcinomas and review of literatures |
Page:920—922 |
| 144. The impact of maternal thyroid diseases on the pregnant outcome in the first trimester of pregnancy |
Page:916—919 |
| 145. Effects of recombinant human growth hormone on final adult height in children with Turner′s syndrome and analysis of the influencing factors |
Page:901—905 |
| 146. Approach to the patients with Gitelman syndrome |
Page:1028—1031 |
| 147. Pharmacoeconomics of the oral antidiabetic drugs in National Essential Medicine |
Page:1021—1024 |
| 148. Effect of sex hormones on secretions of leptin and adiponectin by adipocytes |
Page:1009—1012 |
| 149. Expression and significance of cytokeratin-19, vimentin, vascular endothelial growth factor-C, and cyclooxygenase-2 in Graves' disease and Hashimoto's thyroiditis |
Page:983—987 |
| 150. Cognitive impairment caused by primary hypothyroidism |
Page:979—982 |
| 151. Factors related to the therapeutic efficacy of 131 Ⅰ in Graves' disease |
Page:975—978 |
| 152. Relationship between iodine intake and the prevalence of thyroid disease in Urumqi, Xinjiang |
Page:972—974 |
| 153. Evaluation of desmopressin stimulated bilateral inferior petrosal sinus sampling in diagnosing Cushing′s disease |
Page:880—882 |
| 154. The syndrome of inappropriate antidiuretic hormone secretion: the level on its diagnosis and treatment should be improved |
Page:873—875 |
| 155. Inducing differentiation of human amnion-derived mesenchymal stem cells into insulin-secreting cells in vitro |
Page:1013—1016 |
| 156. Pathogenic diagnosis of sellar mass: be cautious |
Page:957—960 |
| 157. Advance in diagnosis and therapy of pituitary stalk interruption syndrome |
Page:952—956 |
| 158. Effect of simvastatin on toll-like receptor 4 expression in kidney of diabetic rats |
Page:945—946 |
| 159. A preliminary study of serum-deprivation-induced release of S100A13 and flbroblast growth factor 1 from thyroid cancer TT cell |
Page:941—944 |
| 160. Effect of acarbose on fecal bifidobacteria content in patients with type 2 diabetes mellitus |
Page:928—931 |
| 161. Clinical features of gout in female residents in coastal regions of Shandong province |
Page:925—927 |
| 162. A case of congenital nephrogenic diabetes insipidus: his pedigree and clinical evaluation |
Page:922—924 |
| 163. An unique exonic splicing mutation in the CYPI7AI gene as the cause of steroid 17α-hydroxylase deficiency |
Page:911—915 |
| 164. Osteoporosis in Graves′ disease and the characteristics of bone turnover markers |
Page:906—910 |
| 165. A review of clinical characteristics and laboratory data of Alstr(o)m syndrome and two cases report |
Page:897—900 |
| 166. A study on clinical features of ACTH-independent bilateral macronodular adrenal hyperplasia |
Page:892—896 |
| 167. Changes of amino-terminal propeptide of C-type natriuretic peptide and growth velocity in patients with idiopathic short stature or isolated growth hormone deficiency after recombinant human growth hormone treatment |
Page:887—891 |
| 168. Anterior pituitary hypofunction: a clinical analysis of 117 cases |
Page:883—886 |
| 169. Effects of FGF-21 gene knockdown on glucose and lipid metabolism in ApoE-/- mice |
Page:1004—1008 |
| 170. Acute glucagon response associated with the long-term remission of newly-diagnosed type 2 diabetes |
Page:992—995 |
| 171. A survey of the prevalence of diabetes mellitus in adults of Zhejiang province |
Page:988—991 |
| 172. Association of HLA-DRB1 allele polymorphism and ANCA with the susceptibility to antithyroid drug-induced leucocytopenia in patients with Graves' disease |
Page:967—971 |
| 173. Recent progress in identification of candidate genes of Graves' disease |
Page:961—966 |
| 174. The validity of HbA1C detection in diagnosing and screening dysglycemia in children with obesity |
Page:746—748 |
| 175. Immune effect of propylthiouracil and methimazole in the treatment of Graves' disease |
Page:739—742 |
| 176. Association of obesity and hyperandrogenemia with insulin resistance in women with polycystic ovary syndrome |
Page:733—735 |
| 177. Nonalcoholic fatty liver disease related to the severity of coronary artery disease |
Page:729—732 |
| 178. Effects of liraglutide on fibroblast growth factor-21 and its receptors in insulin-resistant mice with hypoadiponectinemia |
Page:775—777 |
| 179. Changes of glucagon and somatostatin levels during oral glucose tolerance test in patients with type 2 diabetes mellitus |
Page:749—751 |
| 180. Prevalence of metabolic syndrome in patients with primary aldosteronism |
Page:724—728 |
| 181. Epidemiological features of metabolic syndrome in residents aged 20-80 years in Pudong New District of Shanghai |
Page:718—723 |
| 182. Obesity-related cardiovascular risk and its appropriate intervention |
Page:707—710 |
| 183. Pay attention to nutritional status in early life: Control later prevalence of obesity should be from its origin |
Page:703—706 |
| 184. The update of the relationship between nonalcoholic fatty liver disease and atherosclerosis |
Page:784—786 |
| 185. Dynamic evaluation of an osteoporosis rabbit model induced by ovariectomy and glucocorticoid with MR spectroscopy and micro-CT |
Page:770—774 |
| 186. Cobalt chloride-induced hypoxia stimulates inflammatory response in adipocytes |
Page:766—769 |
| 187. Effects of low-dose lipopolysaccharide on cell apoptosis, proliferation, and insulin secretion in NIT-1 β-cells |
Page:761—765 |
| 188. Effects of adult catch-up growth on insulin sensitivity and stress in rats |
Page:755—760 |
| 189. Clinical analysis of 330 patients with primry aldosteronism |
Page:752—754 |
| 190. The clinical features of tertiary hyperparathyroidism in 7 cases |
Page:743—745 |
| 191. Analysis on blood glucose excursion in men with nonalcoholic fatty liver disease |
Page:736—738 |
| 192. Role of ω-3 long-chain polyunsaturated fatty acid in metabolic syndrome |
Page:787—790 |
| 193. Approach to the patient of pheochromocytoma: the diagnosis and treatment |
Page:778—781 |
| 194. Protective effect of telmisartan on endoplasmic reticulum stress-related kidney cells apoptosis in diabetic rats |
Page:849—852 |
| 195. Effects of 17β-estradiol and 1,25-dihydroxyvitamin D3 on the proliferation and differentiation of osteoblastic MC3T3-E1 cells |
Page:839—843 |
| 196. A priliminary study on the prevention and early treatment of Nimodipine for type 2 diabetes mellitus with mild cognitive impairment |
Page:836—838 |
| 197. Approach to the patient of insulin autoimmune syndrome: diagnosis and treatment |
Page:857—858 |
| 198. Progress in the protective action of liraglutide on the islet β cells |
Page:877—880 |
| 199. Vildagliptin treatment for type 2 diabetic patients in clinical practice |
Page:873—876 |
| 200. Analysis of risk factors of metabolic syndrome in obese subjects: a follow-up study |
Page:821—824 |
| 201. Prevalence of depression and its risk factors in type2 diabetes mellitus |
Page:796—799 |
| 202. Role of circadian rhythm change in the pathogenesis of obesity and diabetes |
Page:793—795 |
| 203. Hyperglycemia associated with poor prognosis in patients with acute myocardial infarction |
Page:868—872 |
| 204. Recent research progresses of berberine in improving insulin resistance |
Page:864—867 |
| 205. Appoach to the patient with parathyroid adenoma and primary biliary cirrhosis;diagnosis and treatment |
Page:859—861 |
| 206. Up-regulation of monocyte chemoattractant protein-1 in 3T3-L1 adipocytes by CoCl2 induced hypoxia |
Page:853—856 |
| 207. Effect of angiotensin Ⅱ, angiotensin-(1-7) on insulin signaling pathway in NIT-1 cell line |
Page:844—848 |
| 208. Relationship of positive rate of β1-adrenergic and AT1 receptor autoantibodies with serum cystatin C concentration in the patients with diabetic nephropathy |
Page:833—835 |
| 209. Association of hyaluronic acid and soluble intercellular adhesion molecule-1 with the activity of Graves' ophthalmopathy |
Page:830—832 |
| 210. Correlation between the dosage of premixed insulin analogue treatment and continuous subcutaneous insulin infusion treatment in type 2 diabetes |
Page:828—829 |
| 211. Utility of HbA1C in diagnosing diabetes in subjects with hypertension |
Page:825—827 |
| 212. Investigation onto thyroid dysfunction and autoantibody screening in second and third trimesters of pregnancy |
Page:816—820 |
| 213. Relationship between serum matrix metalloproteinase-9 level and coronary heart disease in type 2 diabetic patients |
Page:813—815 |
| 214. Relationship between platelet-leukocyte aggregates and serum high sensitive-C reactive protein in type 2 diabetic patients with retinopathy |
Page:810—812 |
| 215. Plasma ghrelin and peptide YY levels in patients with type 2 diabetes before and after metformin treatment |
Page:805—809 |
| 216. Changes of high sensitive-C reactive protein and cardiac troponin I levels in patients with type 2 diabetes during glucose-lowering therapy |
Page:800—804 |
| 217. Effects of pioglitazone on the expression of genes relative to differentiation and function of primary brown adipose tissue cells in mice with diet-induced obesity |
Page:947—949 |
| 218. The attenuating effect of ursodeoxycholic acid on endoplasmic reticulum stress-mediated pancreatic β-cell apoptosis in streptozotocin-induced diabetic rats |
Page:935—940 |
| 219. Liraglutide, a human glucagon-like peptide-1 analogue, plays a role in reducing body weight in the patients with type 2 diabetes |
Page:703—706 |
| 220. Hyperbaric oxygen therapy in diabetic foot |
Page:700—702 |
| 221. Short and long-term effects of CSII on diabetes after necrotizing pancreatitis |
Page:687—689 |
| 222. Regulation of osteoclast inhibitory lectin ( OCIL ) expression by prostaglandin E2 in rat osteoblastic cells |
Page:683—686 |
| 223. Effect of intermittent high glucose on INS-1 cell proliferation and the expression of skp2-p27 |
Page:673—676 |
| 224. Mutation analysis of thyroid peroxidase gene in 20 Chinese patients with congenital hypothyroidism |
Page:670—672 |
| 225. A comparative study on thyroid function during late pregnancy and of fertile women in iodine excess area |
Page:667—670 |
| 226. Correlation between serum vascular endothelial cells cadherin level and atherosclerosis in diabetic patients |
Page:641—643 |
| 227. Association of angiopoietins and soluble angiopoietin receptor Tie-2 with diabetic retinopathy in patients with type 2 diabetes |
Page:639—641 |
| 228. Iifestyle and diabetes |
Page:692—695 |
| 229. A survey on the current status of type 2 diabetic patients who failed to achieve the glycemic control target |
Page:625—630 |
| 230. Improving quality of care for patients with diabetes comes from investigation of present status and compliance with guidelines --Enlightenment from Early ACTID, ADDITION Europe, and two Chinese surveys |
Page:623—624 |
| 231. Accuracy of blood-glucose monitoring system by using glucose oxidase or glucose dehydrogenase |
Page:634—635 |
| 232. Ezscan: A new non-invasive technology to evidence cardiac autonomic neuropathy in diabetes |
Page:631—633 |
| 233. Progress in the treatment of precocious puberty |
Page:696—699 |
| 234. Effects of high glucose on the expression of angiotensin-converting enzyme/angiotensin converting enzyme 2 in human proximal tubular cells |
Page:680—682 |
| 235. Relationship between liver X receptor (LXR) expression and hepatic glucose metabolism in the insulin resistant obese rats |
Page:677—679 |
| 236. Prevalence of diabetic retinopathy and macular edema in type 2 diabetes patients in the endocrinology department of Tianjin |
Page:664—667 |
| 237. Vitamin D status in healthy adults in Guiyang of China |
Page:659—663 |
| 238. Treatment of idiopathic hypogonadotropic hypogonadism with pulse infusion of gonadorelin via micro pump |
Page:654—658 |
| 239. Association between the 936C/T polymorphism in the 3'-untranslated region of vascular endothelial growth factor gene and diabetic peripheral neuropathy in China |
Page:649—653 |
| 240. Relationship between hearing threshold and peripheral neuropathy in type 2 diabetic patients |
Page:644—648 |
| 241. A survey concerning the knowledge of the Chinese Guidelines of Diabetes Prevention and Treatment among medical staff from hospitals at different levels in Shanghai |
Page:636—638 |
| 242. Efficacy and safety of vildagliptin and metformin combination therapy in type 2 diabetes |
Page:后插1—后插4 |
| 243. DPP-4 inhibitors in the treatment of type 2 diabetes |
Page:后插1—后插4 |
| 244. Improving insulin resistance-the key to prevention and treatment of type 2 diabetes |
Page:后插5—后插6 |
| 245. Viewing at use of glucagon-like peptide-1 in treatment of type 2 diabetes based on the secretion characters of incretins |
Page:后插1—后插4 |
| 246. Vildagliptin: a novel oral anti-diabetic drug in the treatment of type 2 diabetes mellitus |
Page:后插1—后插4 |
| 247. Clinical application of nateglinide:a Chinese expert consensus |
Page:后插1—后插3 |
| 248. Progress in the studies on extra-islet effects of incretin |
Page:后插1—4 |
| 249. The mechanism of the action of dipeptidyl peptidase-4 inhibitors and its use in type 2 diabetes |
Page:后插5—后插8 |
| 250. Islet dysfunction in type 2 diabetes mellitus and incretin-based therapy |
Page:后插1—后插4 |
| 251. Analysis of hypothalamic-pituitary-adrenal axis function in type 2 diabetic patients with different levels of HbA1C |
Page:392—394 |
| 252. Study on glucolipid metabolism and insulin sensitivity in lipoprotein lipase gene knockout heterozygous |
Page:427—429 |
